Control group:Autologous FMT

3 trials

Sponsors

The First Affiliated Hospital of Zhengzhou University

Conditions

Amyotrophic lateral sclerosisParkinson's disease

Phase 1

Effect of Fecal Microbiota Transplantation on Movement Disorders (De novo Parkinson's disease)

RecruitingChiCTR2200064151

The First Affiliated Hospital of Zhengzhou UniversityParkinson's disease

Start: 2022-09-20Updated: 2023-04-17

Effect of Fecal Microbiota Transplantation on Movement Disorders (LRRK2 Associated Parkinson's Disease)

RecruitingChiCTR2200064198

The First Affiliated Hospital of Zhengzhou UniversityParkinson's disease

Start: 2022-09-20Updated: 2023-04-17

Effects of fecal microbiota transplantation on movement disorders (amyotrophic lateral sclerosis)

RecruitingChiCTR2200064504

The First Affiliated Hospital of Zhengzhou UniversityAmyotrophic lateral sclerosis

Start: 2022-10-10Updated: 2023-05-15

Related Papers

Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson’s disease: a randomized phase 2 trial

Signal Transduction and Targeted Therapy2026-03-13